The SURPASS-2 trial showed Mounjaro 15 mg produced nearly twice the weight loss of Ozempic 1 mg in people with type 2 diabetes
Walking 7,000 to 10,000 steps daily is an achievable, sustainable cardiovascular goal for most patients
Study: Using large language models to assess public perceptions around glucagon-like peptide-1 receptor agonists on social media
Aroda VR, Rosenstock J, Wysham C et al (2016) Efficacy and safety of LixiLan, a titratable fixed-ratio combination of insulin glargine plus lixisenatide in type 2 diabetes inadequately controlled on basal insulin and metformin: the LixiLan-L randomized trial
Sermorelin, for example, stimulates the release of growth hormone from the pituitary gland, which can help regulate other hormones and improve overall well-being
These are not just impressive numbers they represent the largest verified review corpus of any GLP-1 telehealth provider we have evaluated, and the near-perfect rating at that scale is remarkable